The Claim
In adults with increased cardiovascular risk, targeting systolic blood pressure below 120 mm Hg compared to higher targets results in consistent reductions in all-cause mortality and major cardiovascular events across subgroups defined by age, sex, diabetes status, and prior cardiovascular disease.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
For adults at higher risk of heart disease, lowering systolic blood pressure to below 120 mm Hg reduces deaths and serious heart events consistently, regardless of age, sex, diabetes status, or prior heart disease.
See the scientific wording
In adults with increased cardiovascular risk, the benefit of targeting systolic blood pressure below 120 mm Hg on all-cause mortality and major cardiovascular events is consistent across subgroups including age, sex, diabetes status, and prior cardiovascular disease, based on pooled subgroup analyses from five randomized trials.
Lowering blood pressure reduces the force pushing against artery walls, which prevents damage to the inner lining of blood vessels. This stops the buildup of fatty plaques and makes existing plaques less likely to break open, which prevents heart attacks and strokes.
What the research says
1 studyFor people at high risk of heart problems, lowering blood pressure to under 120 helped reduce deaths and heart events—and this benefit was seen in men, women, older and younger people, and those with or without diabetes or prior heart disease.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.